Patents by Inventor Xiaoyan Pang

Xiaoyan Pang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10285984
    Abstract: A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.
    Type: Grant
    Filed: June 4, 2013
    Date of Patent: May 14, 2019
    Assignee: Shanghai Jiao Tong University
    Inventors: Liping Zhao, Xu Zhang, Menghui Zhang, Yufeng Zhao, Xiaoyan Pang, Xiaojun Zhang, Linghua Wang, Guang Ning, Xiaoying Li, Yifei Zhang
  • Publication number: 20150119415
    Abstract: A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.
    Type: Application
    Filed: June 4, 2013
    Publication date: April 30, 2015
    Inventors: Liping Zhao, Xu Zhang, Menghui Zhang, Yufeng Zhao, Xiaoyan Pang, Xiaojun Zhang, Linghua Wang, Guang Ning, Xiaoying Li, Yifei Zhang
  • Patent number: 8097417
    Abstract: Non-invasive methods for monitoring the effect of an agent for treating colorectal cancer, comprising (1) collecting fecal samples from healthy subjects, subjects having precancerous lesions, and subject having precancerous lesions and being treated with an anti-cancer agent; (2) isolating total microbial genomic DNA from the fecal samples to provide total microbial genomic DNA; (3) comparing the total microbial genomic DNA using fingerprint spectrum analysis; (4) identifying key fingerprint bands correlated with the effect of the anti-cancer agent; (5) identifying key microorganisms associated with the key fingerprint bands; (6) designing microbial sequence-specific primers and probes; and (7) determining the quantitative differences of the key microorganisms in fecal samples to identify an indicator microorganism for monitoring the effect of the anti-cancer agent.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: January 17, 2012
    Inventors: Liping Zhao, Wei Hua, Xiaoyan Pang, Jia Wei, Dazheng Wu
  • Publication number: 20100112564
    Abstract: precancerous lesions, and subject having precancerous lesions and being treated with an anti-cancer agent; (2) isolating total microbial genomic DNA from the fecal samples to provide total microbial genomic DNA; (3) comparing the total microbial genomic DNA using fingerprint spectrum analysis; (4) identifying key fingerprint bands correlated with the effect of the anti-cancer agent; (5) identifying key microorganisms associated with the key fingerprint bands; (6) designing microbial sequence-specific primers and probes; and (7) determining the quantitative differences of the key microorganisms in fecal samples to identify an indicator microorganism for monitoring the effect of the anti-cancer agent.
    Type: Application
    Filed: February 23, 2009
    Publication date: May 6, 2010
    Applicant: Shanghai Jiao Tong University
    Inventors: Liping Zhao, Wei Hua, Xiaoyan Pang, Jia Wei, Dazheng Wu